Single dose of inhaled procaterol has a prolonged effect on exercise performance of patients with COPD

Physiotherapy Theory and Practice

Volumn 24, Issue 4, 2008, Pages 255-263

  Sukisaki, Toshitaka ^a   Senjyu, Hideaki ^a   Oishi, Kazunori ^b   Rikitomi, Naoto ^c   Ariyoshi, Koya ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c Nagasaki Pulmonary Rehabilitation Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROCATEROL;

AGED; ANALYTIC METHOD; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DRUG EFFECT; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MALE; PREDICTION; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SPIROMETRY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; WALKING;

ADMINISTRATION, INHALATION; AGED; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MUSCLE FATIGUE; PROCATEROL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WALKING;

EID: 46049104180     PISSN: 09593985     EISSN: 15325040     Source Type: Journal    
DOI: 10.1080/09593980701686815     Document Type: Article

References (41)

1. Aalbers R, Ayres J, Backer V, Decramer M, Lier PA, Magyar P, Malolepszy J, Ruffin R, Sybrecht GW 2002 Formoterol in patients with chronic obstructive pulmonary disease: A randomized, controlled, 3-month trial. European Respiratory Journal 19: 936-943
2. American Thoracic Society 2002 ATS statement: Guidelines for the six-minute walk test. American Journal of Respiratory and Critical Care Medicine 166: 111-117
3. American Thoracic Society/American College of Chest Physicians 2003 ATS/ACCP Statement on cardiopulmonary exercise testing. American Journal of Respiratory and Critical Care Medicine 167: 211-277
4. Baronti A, Lelli M, Manini G, Verdiani P 1987 Procaterol metered aerosol in patients with chronic obstructive pulmonary disease. International Journal of Clinical Pharmacology Research 7: 363-368
5. Belman MJ, Botnick WC, Shin JW 1996 Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 153: 967-975
6. Berger R, Smith D 1988 Effect of inhaled metaproterenol on exercise performance in patients with stable "fixed" airway obstruction. American Review of Respiratory Disease 138: 624-629
7. Borg GA 1982 Psychophysical bases of perceived exertion. Medicine and Science in Sports and Exercise 14: 377-381
8. Casaburi R, Kukafka D, Cooper CB, Witek TJ, Kesten S 2005 Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest 127: 809-817
9. Chetta A, Del Donno M, Maiocchi G, Pisi G, Moretti D, Olivieri D 1993 Prolonged bronchodilating effect of formoterol versus procaterol in bronchial asthma. Annals of Allergy 70: 171-174
10. Curtis JR 1996 Assessing health-related quality of life in chronic pulmonary disease. In: Alfred PF (ed) Pulmonary Rehabilitation, Lung Biology in Health and Disease, pp 329-353. New York, Marcel Dekker
11. Dyer CA, Singh SJ, Stockley RA, Sinclair AJ, Hill SL 2002 The incremental shuttle walking test in elderly people with chronic airflow limitation. Thorax 57: 34-38
12. Elpern EH, Stevens D, Kesten S 2000 Variability in performance of timed walk tests in pulmonary rehabilitation programs. Chest 118: 98-105
13. Guyatt GH, Pugsley SO, Sullivan MJ, Thompson PJ, Berman L, Jones NL, Fallen EL, Taylor DW 1984 Effect of encouragement on walking test performance. Thorax 39: 818-822
14. Hay JG, Stone P, Carter J, Church S, Eyre-Brook A, Pearson MG, Woodcock AA, Calverley PM 1992 Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. European Respiratory Journal 5: 659-664
15. Hoffstein V, Zamel N, McClean P, Chapman KR 1994 Changes in pulmonary function and cross-sectional area of trachea and bronchi in asthmatics following inhalation of procaterol hydrochloride and ipratropium bromide. American Journal of Respiratory and Critical Care Medicine 149: 81-85
16. Ikeda A, Nishimura K, Koyama H, Tsukino M, Mishima M, Izumi T 1996 Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease. Thorax 51: 48-53
17. Kazuhiro S, Takanobu S, Masahiro S, Hazuki S, Noritaka K, Mayumi D, Chikage K, Tomoko S, Keiyu S, Hitomi T, Hitoshi K, Nobuaki I, Mitunobu H 2003 Effect of β2 receptor agonist in patients with chronic obstructive pulmonary disease: With special reference to the effect on QOL and ADL. Journal of Japan Society for Respiratory Care 12: 318-325
18. Kikuchi Y, Yanai M, Taguchi O, Sekizawa K, Hida W, Sasaki H, Takishima T 1989 [New methods for measurement of peripheral airway resistance]. Nihon Kyobu Shikkan Gakkai Zasshi 27: 1401-1406
19. Liippo K, Silvasti M, Tukiainen H 1991 Inhaled procaterol versus salbutamol in bronchial asthma. European Journal of Clinical Pharmacology 40: 417-418
20. Littner MR, Ilowite JS, Tashkin DP, FriedmanM, Serby CW, Menjoge SS, Witek TJ 2000 Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 161: 1136-1142
21. MacIntyre NR 2001 Chronic obstructive pulmonary disease management: The evidence base. Respiratory Care 46: 1294-1303
22. Man WD, Soliman MG, Gearing J, Radford SG, Rafferty GF, Gray BJ, Polkey MI, Moxham J 2003 Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 168: 562-567
23. Mazza JA, Tashkin DP, Reed CE 1992 Evaluation of procaterol and albuterol (salbutamol) aerosol in the treatment of asthma. Annals of Allergy 68: 267-273
24. Mitsuhashi M, Kimura T, Tateno K, Morikawa A, Kuroume T 1985 Effect of inhaled procaterol hydrochloride in children with bronchial asthma, with particular reference to duration of effect. Journal of Asthma 22: 203-207
25. Obata T, Matsuda S, Akasawa A, Iikura Y 1993 Preventive effect and duration of action of disodium cromoglycate and procaterol on exercise-induced asthma in asthmatic children. Annals of Allergy 70: 123-126
26. O'Donnell DE, Flüge T, Gerken F, Hamilton A, Webb K, Aguilaniu B, Make B, Magnussen H 2004 Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. European Respiratory Journal 23: 832-840
27. O'Donnell DE, Forkert L, Webb KA 2001 Evaluation of bronchodilator responses in patients with "irreversible" emphysema. European Respiratory Journal 18: 914-920
28. O'Donnell DE, Revill SM, Webb KA 2001 Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 164: 770-777
29. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS 2001 Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. American Journal of Respiratory and Critical Care Medicine 163: 1256-1276
30. Prefaut CA, Varry A, Vallet G 1995 Pathophysiological basis of exercise training in patients with chronic obstructive lung disease. European Respiratory Review 5: 27-32
31. Rennard SI, Serby CW, Ghafouri M, Johnson PA, Friedman M 1996 Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials. Chest 110: 62-70
32. Sciurba F, Criner GJ, Lee SM, Mohsenifar Z, Shade D, Slivka W, Wise RA 2003 Six-minute walk distance in chronic obstructive pulmonary disease: Reproducibility and effect of walking course layout and length. American Journal of Respiratory and Critical Care Medicine 167: 1522-1527
33. Shapiro GG, Kemp JP, DeJong R, Chapko M, Bierman CW, Altman LC, Furukawa CT, Meltzer E, Orgel A, Pierson WE 1990 Effects of albuterol and procaterol on exercise-induced asthma. Annals of Allergy 65: 273-276
34. Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE 1992 Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 47: 1019-1024
35. Solway S, Brooks D, Lacasse Y, Thomas S 2001 A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 119: 256-270
36. Somand H, Remington TL 2005 Tiotropium: A bronchodilator for chronic obstructive pulmonary disease. Annals of Pharmacotherapy 39: 1467-1475
37. Storms WW, Chervinsky P, Bell T, Kemp JP, Brandon ML, Reed CE, Siegel SC, Repsher L 1989 Procaterol metered-dose inhaler: A multiclinic study evaluating the efficacy and safety in patients with asthma. Annals of Allergy 63: 444-448
38. van Noord JA, Aumann JL, Janssens E, Smeets JJ, Verhaert J, Disse B, Mueller A, Cornelissen PJ 2005 Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD. European Respiratory Journal 26: 214-222
39. van Noord JA, Bantje TA, Eland ME, Korducki L, Cornelissen PJ 2000 A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group. Thorax 55: 289-294
40. Wadbo M, Löfdahl CG, Larsson K, Skoogh BE, Tornling G, Arweström E, Bengtsson T, Ström K 2002 Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study. European Respiratory Journal 20: 1138-1146
41. Yusen R 2001 What outcomes should be measured in patients with COPD?. Chest 119: 327-328